Foghorn Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $80.9M | $55.5M | $80.3M | $52.2M | $101.1M | $92.8M | $15.0M | $40.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $163.2M | $249.6M | $240.2M | $351.4M | $459.6M | $190.7M | $16.9M | — |
| Property, Plant & Equipment | — | — | — | — | — | $19.5M | $2.7M | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $198.1M | $284.0M | $285.9M | $404.9M | $519.8M | $255.6M | $22.3M | — |
| Liabilities | ||||||||
| Accounts Payable | $4.3M | $3.8M | $6.3M | $5.4M | $3.8M | $3.7M | $3.4M | — |
| Total Current Liabilities | $59.7M | $67.0M | $58.4M | $55.2M | $48.7M | $18.8M | $12.7M | — |
| Long-Term Debt | — | — | — | — | $0 | $19.7M | $11.0M | — |
| Total Liabilities | $306.6M | $329.5M | $363.1M | $404.8M | $422.9M | $109.4M | $23.8M | — |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-632.5M | $-558.2M | $-471.6M | $-373.1M | $-264.3M | $-162.9M | $-94.1M | — |
| Total Stockholders' Equity | $-108.5M | $-45.5M | $-77.2M | $112.0K | $96.9M | $146.2M | $-88.0M | $-39.3M |